Class Action Lawsuit Filed Against Sana Biotechnology for Investor Losses

LOS ANGELES
,

April 24, 2025

/PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, has issued a reminder to investors about a class action lawsuit against Sana Biotechnology, Inc. (“Sana” or “the Company”) SANA for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 as established by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities from March 17, 2023 to November 4, 2024, are encouraged to contact the firm before May 20, 2025.

Shareholders who experienced losses should consider participating in the lawsuit.

Interested parties can contact Brian Schall of the Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. Reach him at 310-301-3335 or visit the firm’s website at www.schallfirm.com.

Please note that the class in this case has not yet been certified. Until certification occurs, you are not represented by an attorney. If you choose not to act, you may remain an absent class member.

According to the Complaint, the Company allegedly provided false and misleading statements. These statements suggested that Sana had sufficient funding for operations and development of its product candidates. In reality, several product candidates were reportedly less promising than advertised, leading to potential funding cuts and staff reductions. When the market learned the truth, investors faced significant losses.

Participating in this case may provide shareholders a chance to recover losses.

The Schall Law Firm focuses on representing investors globally through securities class action lawsuits and shareholder rights litigation.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

Office: 310-301-3335

[email protected]